Significance:
Tumor suppressor PTEN is the second most mutated gene in human cancer. This study suggests, for the first time, that MiR-561, by suppressing the expression of its target gene, it may increase the expression of PTEN. Thus, pharmacological formulations encompassing “MiR-561 or its activators“ may be used to used to treat human cancers that retain wild-type PTEN.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org or newbioideas.com
To cite: Boominathan, MiR-therapy for Human Cancers: MiR-561 increases the expression of tumor suppressor PTEN via down-regulation of its target gene, 13/October/2015, 8.01 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
# Research cooperation
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Undisclosed information: How MiR-561 increases the expression of tumor suppressor PTEN.
Amount: $100
Results guaranteed if not refunded